Locally Advanced Squamous Non-Small Cell Lung Cancer
1 competing product in clinical development for Locally Advanced Squamous Non-Small Cell Lung Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Necitumumab + Gemcitabine + Carboplatin | Eli Lilly | Phase 2 | Withdrawn | 52 |